CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Hallmarks of Cancer: Deregulating Cellular Energetics

Read More
All Posts

Cancer cells need a lot of energy to grow fast—to do so, they show abnormal metabolic pathways.

Most mammalian cells use glucose as a fuel source. Glucose is metabolized by glycolysis in a multistep set of reactions, resulting in the creation of pyruvate. In typical cells under normal oxygen levels, much of this pyruvate enters the mitochondria, where it is oxidized by the Krebs Cycle to generate ATP to meet the cell’s energy demands.

18-CEL-47388-Blog-Hallmarks-Cancer-2-Deregulating-Cellular-Energetics

However, in cancer cells or other highly proliferative cell types, much of the pyruvate from glycolysis is directed away from the mitochondria to create lactate through the action of lactate dehydrogenase (LDH/LDHA)—a process typically reserved for the low oxygen state. In contrast to mitochondrial glycolysis, lactate production in the presence of oxygen is termed “aerobic glycolysis” or the Warburg Effect. Several signaling pathways contribute to the Warburg Effect and other metabolic phenotypes of cancer cells. If you look at the pathway, you might notice PI3K/Akt, mTOR, Erk1/2 MAPK, ULK1 (Autophagy), p53, HIF1alpha, (HypoxiaAngiogenesis), and AMPK all represented.

Cancer cells frequently use glutamine as another fuel source, which enters the mitochondria and can be used to replenish Krebs Cycle intermediates or to produce more pyruvate through the action of malic enzyme, or to produce building blocks to help the increased cell growth.

Cancer cells can become addicted to glutamine, with glutamine itself promoting cell proliferation. For this reason, glutamine metabolism is becoming a hot research area for cancer researchers. Because glycolysis is an intricate process, influenced by so many factors, there are many pathways to research. Check out some of these signaling players today.

Check out the complete guide to the Hallmarks of Cancer Research targets. Download the eBook Now.

The Hallmarks of Cancer are seminal manuscripts by Doctors Robert Weinberg and Douglas Hanahan and were published in Cell1. The authors proposed the idea that the complexity of cancer can be broken down into smaller subsets of underlying principles. The information here pertains to one Hallmark of Cancer, known as "Deregulating Cellular Energetics." Other entries in this series explore the other proposed Hallmarks.

Read the additional blog posts in the Hallmarks of Cancer series to learn more:

References:

  1. Hanahan D, Weinberg RA (January 2000). "The Hallmarks of Cancer". Cell. 100 (1): 57–70. doi:10.1016/S0092-8674(00)81683-9
  2. Hanahan D, Weinberg RA (March 2011). "Hallmarks of Cancer: the next generation". Cell. 144 (5):646-74. doi: 10.1016/j.cell.2011.02.013
Chris Sumner
Chris Sumner
Chris Sumner was the Editor-in-Chief of Lab Expectations. When he's not reading/writing about curing disease, he's hiking in the woods, playing guitar, or searching for the world's best lobster roll.

Recent Posts

Microglial Activation Antibody Toolkit: High-Content Methods to Study TREM2 Signaling

Selecting antibodies for molecular signaling research in neurodegeneration is a complex and nuanced proce...
Ginny Bain, PhD Dec 11, 2024

Cell Preparation Tips for Accurate Flow Cytometry Data

Generating accurate flow cytometry data requires more than just specific and sensitive antibodies validat...
Andrea Tu, PhD Nov 20, 2024

500 Antibodies & Counting: Accelerating Discovery with CST Antibodies Validated for Simple Western Technology

Since 2022, Cell Signaling Technology (CST) and Bio-Techne have been working together to bring best-in-cl...
Chris LaBreck, PhD Oct 23, 2024